Lotus Pharmaceutical Valuation
| 1795 Stock | TWD 265.00 1.00 0.38% |
At this time, the firm appears to be fairly valued. Lotus Pharmaceutical secures a last-minute Real Value of NT$254.72 per share. The latest price of the firm is NT$265.0. Our model forecasts the value of Lotus Pharmaceutical from analyzing the firm fundamentals such as Profit Margin of 0.22 %, return on equity of 0.26, and Current Valuation of 73.53 B as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Lotus Pharmaceutical's price fluctuation is very steady at this time. Calculation of the real value of Lotus Pharmaceutical is based on 3 months time horizon. Increasing Lotus Pharmaceutical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Lotus stock is determined by what a typical buyer is willing to pay for full or partial control of Lotus Pharmaceutical Co. Since Lotus Pharmaceutical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Lotus Stock. However, Lotus Pharmaceutical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 265.0 | Real 254.72 | Hype 265.0 |
The intrinsic value of Lotus Pharmaceutical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Lotus Pharmaceutical's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Lotus Pharmaceutical Co helps investors to forecast how Lotus stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Lotus Pharmaceutical more accurately as focusing exclusively on Lotus Pharmaceutical's fundamentals will not take into account other important factors: Lotus Pharmaceutical Total Value Analysis
Lotus Pharmaceutical Co is presently anticipated to have takeover price of 73.53 B with market capitalization of 70.1 B, debt of 4.67 B, and cash on hands of 1.97 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Lotus Pharmaceutical fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
73.53 B | 70.1 B | 4.67 B | 1.97 B |
Lotus Pharmaceutical Investor Information
About 62.0% of the company shares are owned by insiders or employees . The book value of Lotus Pharmaceutical was presently reported as 51.3. The company recorded earning per share (EPS) of 11.86. Lotus Pharmaceutical last dividend was issued on the 4th of August 2022. The entity had 1060:1000 split on the 8th of September 2010. Lotus Pharmaceutical Co is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.Lotus Pharmaceutical Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Lotus Pharmaceutical has an asset utilization ratio of 59.6 percent. This indicates that the Company is making NT$0.6 for each dollar of assets. An increasing asset utilization means that Lotus Pharmaceutical Co is more efficient with each dollar of assets it utilizes for everyday operations.Lotus Pharmaceutical Ownership Allocation
Lotus Pharmaceutical maintains a total of 262.04 Million outstanding shares. Lotus Pharmaceutical Co secures majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 61.63 % of Lotus Pharmaceutical Co outstanding shares that are owned by insiders conveys that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.Lotus Pharmaceutical Profitability Analysis
The company reported the revenue of 12.65 B. Net Income was 1.4 B with profit before overhead, payroll, taxes, and interest of 5.64 B.About Lotus Pharmaceutical Valuation
Our relative valuation model uses a comparative analysis of Lotus Pharmaceutical. We calculate exposure to Lotus Pharmaceutical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Lotus Pharmaceutical's related companies.Lotus Pharmaceutical Co., Ltd. researches, develops, manufactures, and sells medicines in Taiwan, Korea, the United States, and internationally. Lotus Pharmaceutical Co., Ltd. is a subsidiary of Alvogen Emerging Markets Holdings Limited. LOTUS PHARMACEUTICAL operates under Drug ManufacturersSpecialty Generic classification in Taiwan and is traded on Taiwan Stock Exchange.
8 Steps to conduct Lotus Pharmaceutical's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Lotus Pharmaceutical's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Lotus Pharmaceutical's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Lotus Pharmaceutical's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Lotus Pharmaceutical's revenue streams: Identify Lotus Pharmaceutical's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Lotus Pharmaceutical's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Lotus Pharmaceutical's growth potential: Evaluate Lotus Pharmaceutical's management, business model, and growth potential.
- Determine Lotus Pharmaceutical's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Lotus Pharmaceutical's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Lotus Stock Analysis
When running Lotus Pharmaceutical's price analysis, check to measure Lotus Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lotus Pharmaceutical is operating at the current time. Most of Lotus Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Lotus Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lotus Pharmaceutical's price. Additionally, you may evaluate how the addition of Lotus Pharmaceutical to your portfolios can decrease your overall portfolio volatility.